Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Complete Genomics Maps Processes with Lanner

Published: Monday, July 29, 2013
Last Updated: Monday, July 29, 2013
Bookmark and Share
Human genome company selects WITNESS predictive simulation technology to support decision-making and boost throughput.

Lanner announced that Complete Genomics has invested in its WITNESS predictive simulation platform.  The agreement means WITNESS will simulate and optimise business processes at Complete Genomics to enhance the provision of highly accurate, human genome data, ready for interpretation, to biological researchers.

Having selected WITNESS based on its ability to rapidly model the complex, interconnected processes used to deliver accurate DNA sequencing, Matt Morenzoni, Biomolecular Systems Scientist, Complete Genomics comments, “In an industry driven by innovation, precision and speed it is imperative that the best business outcomes are found most effectively.”

Mandy Tague, Lanner director of business development, says, “By choosing predictive simulation to gain insight into the operations of their business, Complete Genomics will be able to make confident decisions that will allow them to meet the increasing demand for their services.”

She continues, “Experimenting with the firm's end-to-end service methods that include process automation, sample preparation, computing infrastructure, and service delivery technology allows Complete Genomics to maximise throughput.   This provides the firm's research clients with highly accurate genomic data, assembled and annotated, ready for biological interpretation with optimum efficiency.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
NIH Launches Early-Stage Yellow Fever Vaccine Trial
Researchers at NIH have begun an early-stage clinical trial of an investigational vaccine designed to protect against yellow fever virus.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!